By Emily Blackburne
have teamed up to train future doctors and researchers from underrepresented groups, while also addressing cancer health disparities in minority populations.
In 2001, Dr. Harold Varmus, a Nobel Prize-winning cancer researcher and then president and CEO of MSK, approached CCNY faculty, none of whom were involved in direct cancer research at the time, to form a partnership between CCNY and MSK., the Principal Investigator of this partnership and a professor at CCNY, brought her expertise on cellular aging, a key factor in carcinogenesis, to the program. As a leading cancer research and treatment center in the U.S., MSK sought to go further and find solutions for the inequalities of the healthcare system, specifically in cancer diagnosis and treatment. CCNY faculty including Hubbard, contributed their research to the program to address cancer disparities.
in the U.S. are grim, with black women facing higher mortality rates from breast and cervical cancers, and black Americans having the highest cancer mortality rates overall. These statistics prompted MSK to form a partnership with CCNY, one of the most diverse student campuses in the country, to work towards solutions.
���In order to make a dent in this problem, you really have to work at it from different angles, and you have to do them almost simultaneously,��� Hubbard says. The CCNY-MSKCC partnership is unique, approaching cancer health disparity by combining research, community outreach, and training.
The CCNY-MSKCC partnership primarily serves underrepresented undergraduate students, with over 60% of students coming from minority or underserved backgrounds, with twice as many female students as male students funded by the program. The program lasts a year and offers summer stipends, career development activities and seminar series throughout the school year. In the fall, all students also attend the (ABRCMS) for networking and professional opportunities.
These resources have helped students build connections for post-graduate studies and careers over the past 15 years. Initially the program focused on training undergraduate students. In 2013, the program extended to include graduate and postdoctoral students, resulting in the program training nearly 200 undergraduate students, 10 Ph.D. students, 6 postdocs, and 5 M.S. trainees since its inception. Many of the undergraduate students go onto Ph.D. or M.D. degree programs or directly into research or medical-related jobs. For example, CCNY Clinical Psychology Ph.D. graduate, Dr. Florence Liu, who focused on immigrant health during her postdoctoral work in the program, was hired as an assistant attending faculty member at MSKCC. Dr. Lingyan Shi, a postdoctoral trainee in CCNY professor, helped research improved imaging for detecting and treating triple-negative breast cancer (a cancer type that women of color are to be diagnosed with), and later secured a position as a faculty member at the Shu Chien-Gene Lay Department of Bioengineering at the University of California at San Diego.
CCNY faculty have also collaborated with MSKCC on projects focused on cancer disparities. Dr. Hubbard worked with, director of the Neurocognitive Research Lab at MSK, to study cognitive impairment following chemotherapy. Their research may indicate that minority women, who experience higher stress levels, are more susceptible to “” or cognitive impairment after chemotherapy.
The CCNY-MSKCC partnership funds several other projects targeting cancer-related disparities. One initiative focuses on lung and oral cancer risks among South Asian taxi drivers, who are exposed to traffic pollutants and use chewing tobacco frequently. Another project collaborates with the Mexican consulate to create educational materials on HPV, addressing stigmas and fears about HPV vaccination in Hispanic communities.
Faculty also benefit from the CCNY-MSKCC partnership. ���If it hadn’t been for the partnership they wouldn���t have started doing cancer research. It���s been very instrumental in their careers,��� Hubbard says about participating faculty members. The program���s faculty comes from a broad scope of departments including biology, physics, psychology, and engineering, giving the program an interdisciplinary edge. Faculty can also apply for pilot funding from the program to advance their research, and junior faculty have progressed from assistant to associate to full professors in cancer research through the partnership., for example, was promoted from assistant to associate professor of biomedical engineering at CCNY, and was awarded an for his research on chronic disease treatments, a project developed through the CCNY-MSKCC partnership., newly promoted to associate medical professor with tenure at CUNYSchool of Medicine, received that has allowed her to further her research on HIV/STD prevention interventions for minority adolescent populations.
Through networking in the program, Hubbard is currently working on a project which focuses on addressing cancer health disparities in clinical trials. In this project she is collaborating with Dr. Maria Contel, the director of the, BCCC-CURE, on a new ruthenium-based chemotherapy drug that is less toxic to the body than current treatments.
���Whether they���re students or faculty members, it���s about exposing people to the possibilities of what they can do, and the types of research they can pursue related to cancer disparities,��� says Hubbard. The CCNY-MSKCC partnership acts as an entry point, opening doors for more equitable career opportunities, and cancer research and treatment.
